In addition to stabilization of the BCR signal, experimental evidence indicates that HSP90 may also regulate the FGFR signal by chaperoning the constitutively active FGFR3 in CLL cells. The gene discussed is FGFR3; the disease is B-cell chronic lymphocytic leukemia.